SCHEMBL7708144

SCHEMBL7708144

CC1Oc2ccc(C(Cc3ccc(F)cc3)NC(=O)OC(C)(C)C)cc2NC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.42
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
JAK2 O60674 1/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
CCKAR P32238 1/20 0.37
CCKBR P32239 1/20 0.37
SMYD3 Q9H7B4 3/20 0.36
IDO1 P14902 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7713294 0.92 PARP1 (0.42) PARP1ALDH1A1HTTJAK2TP53
SCHEMBL7713338 0.91 PARP1 (0.42) PARP1ALDH1A1TP53HSD17B10TSHR
SCHEMBL7713374 0.91 PARP1 (0.50) PARP1CTSSCTSKALDH1A1HTT
SCHEMBL7713251 0.91 CTSS (0.45) PARP1CTSSCTSKALDH1A1HTT
SCHEMBL7087725 0.90 CTSS (0.41) CTSSCTSKALDH1A1HTTJAK2
SCHEMBL7711371 0.90 PARP1 (0.41) PARP1ALDH1A1HTTTP53HPGD
SCHEMBL7708029 0.90 PARP1 (0.41) PARP1CTSSCTSKALDH1A1HTT
SCHEMBL7708221 0.89 PARP1 (0.40) PARP1ALDH1A1HTTJAK2TP53
SCHEMBL7713423 0.88 PARP1 (0.41) PARP1ALDH1A1TP53HSD17B10TSHR
SCHEMBL7710382 0.87 PARP1 (0.40) PARP1HPGDMEN1KMT2ASMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed